Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial.

@article{Mentz2013InfluenceOD,
  title={Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial.},
  author={Robert J. Mentz and Bradley D. Allen and Mary J. Kwasny and Marvin A. Konstam and James E. Udelson and Andrew P. Ambrosy and Angela J. Fought and Muthiah Vaduganathan and Christopher M. O'Connor and Fa{\"i}ez Zannad and Aldo Pietro Maggioni and Karl Swedberg and Robert Ogden Bonow and Mihai Gheorghiade},
  journal={European journal of heart failure},
  year={2013},
  volume={15 1},
  pages={61-8}
}
AIMS Data on the prognosis of heart failure (HF) patients with coronary artery disease (CAD) have been conflicting. We describe the clinical characteristics and mode-specific outcomes of HF patients with reduced ejection fraction (EF) and documented CAD in a large randomized trial. METHODS AND RESULTS EVEREST was a prospective, randomized trial of vasopressin-2 receptor blockade, in addition to standard therapy, in 4133 patients hospitalized with worsening HF and reduced EF. Patients were… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 38 references

Rosuvastatin in older patients with systolic heart failure.

Current atherosclerosis reports • 2009
View 6 Excerpts
Highly Influenced

Coronary artery bypass surgery in patients with left ventricular dysfunction.

The American journal of medicine • 1986
View 6 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…